Lenalidomide therapy in treatment refractory cutaneous lupus erythematosus: Histologic and circulating leukocyte profile and potential risk of a systemic lupus flare

BACKGROUND: Lenalidomide is a thalidomide analogue that may serve as an adjunctive therapy for treatment refractory cutaneous lupus erythematosus (CLE). OBJECTIVES: We evaluate the use of lenalidomide in CLE and describe the skin and circulating leukocyte profile of treatment refractory patients bef...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Braunstein, I, Goodman, NG, Rosenbach, M, Okawa, J, Shah, A, Krathen, M, Kovarik, CL, Luning Prak, E, Werth, VP
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3306524/
https://ncbi.nlm.nih.gov/pubmed/21821308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2011.01.015
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi